MLANA and melanoma: Although not the primary aim of this study, the experiments conducted in Figs. 6 and 9 allowed us to define the specificities (HLA A2, melan A ELAGIGILTV) of the two dominant persistent melanoma-reactive clonotypes found in the blood of patient MM909.24 after complete remission.